Sponsor Dossier
Echo Therapeutics
Sponsor Dossier for Echo Therapeutics. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
About
Echo Therapeutics is an Australian Private Company with ABN 92628298699, registered in NSW and currently active.
Portfolio
Echo Therapeutics has 6 brands on the ARTG, of which 6 are indexable and 6 carry a Product Information document. 2 brands are PBS-listed, 2 have a PBAC outcome on record, and 0 have an AusPAR on record. Notable brands include BACTRIM, CALCIUM, MITOCIN, PEGASYS, RESONIUM, TEMGESIC.
Therapeutic focus
— Renal: 2 brands — Oncology: 1 brand — Pain Management: 1 brand — Hepatology: 1 brand — Infectious Disease: 1 brand
PBS footprint
2 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2017-11-01, across 2 brands with a PBAC outcome on record.